Cambridge life science cluster’s most exciting companies, has gone through a huge overhaul in the boardroom – including a ...
China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory measures against fresh US ...
In its fourth quarter 2024 investor letter, Brown Advisors Global Leaders Strategy emphasized stocks such as Illumina, Inc. (NASDAQ:ILMN). Illumina, Inc. (NASDAQ:ILMN) offers sequencing- and array ...
BEIJING’S surprise move to blacklist Illumina has unleashed a frenzy among the US firm’s Chinese rivals to win market share from the gene-sequencing giant. While Illumina is still assessing the ...
Follow us on Facebook and join our Telegram channel for the latest updates. Prime Minister and Finance Minister Lawrence Wong mentioned Illumina, the Nasdaq-listed biotechnology firm headquartered in ...
For the first time, China has put American genome-sequencing equipment manufacturer Illumina on its “unreliable entity list”. The move was a direct counter to the US imposing sanctions on Beijing ...
Syngenta Group was the largest competitor with a 3.47% share of the market, followed by Amgen Inc with 3.29%, Monsanto (Bayer) AG with 1.48%, Illumina Inc with 1.20%, F. Hoffmann-La Roche Ltd ...
Syngenta Group was the largest competitor with a 3.47% share of the market, followed by Amgen Inc with 3.29%, Monsanto (Bayer) AG with 1.48%, Illumina Inc with 1.20%, F. Hoffmann-La Roche Ltd.
That morning, Barclays changed its recommendation on Illumina stock to underweight (read: sell) from the previous equal weight (hold). It also pulled the lever on a significant price target ...
(RTTNews) - Below are the earnings highlights for Illumina Inc. (ILMN): Earnings: $187 million in Q4 vs. -$176 million in the same period last year. EPS: $1.17 in Q4 vs. -$1.11 in the same period ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results